Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2961 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Novartis and Lonza partner in biologics development

Under the partnership with Lonza, each project will have a specific development agreement. Following successful development of a compound, Novartis can choose to transfer the commercial manufacturing in-house.

US drug industry revises marketing code

The revised code, which builds on improvements already made in the previous 2002 version, is part of an ongoing effort to ensure that pharmaceutical marketing practices comply with

BioMarker Strategies names new CEO

Ms Olson is the former president and CEO of Adhesives Research, a $115 million multinational specialty chemical and drug delivery company. In addition to holding an executive MBA

Altus signs hormone supply agreement with Sandoz

Altus is developing ALTU-238 as a subcutaneously administered, long-acting formulation of rhGH that employs the company’s proprietary protein crystallization and formulation technology. Sandoz supplied rhGH for Altus’s completed